Glenmark Pharmaceuticals informs about transcript of earnings call

19 Feb 2024 Evaluate

Further to letter dated 2nd February, 2024 and pursuant to Regulation 30(6) read with Part A of Schedule III of SEBI (LODR), Regulations 2015, Glenmark Pharmaceuticals has informed that it enclosed the transcript of the Earnings call held on Friday, February 16, 2024 for the third quarter and nine months ended December 31, 2023 has been uploaded on the Company’s website.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1054.25 -17.40 (-1.62%)
30-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1502.30
Dr. Reddys Lab 6198.90
Cipla 1402.20
Zydus Lifesciences 957.00
Lupin 1645.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.